Matches in Wikidata for { <http://www.wikidata.org/entity/Q91525413> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q91525413 description "article scientifique publié en 2020" @default.
- Q91525413 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91525413 description "scientific article published on 03 April 2020" @default.
- Q91525413 description "wetenschappelijk artikel" @default.
- Q91525413 description "наукова стаття, опублікована 3 квітня 2020" @default.
- Q91525413 name "Innovative therapies for acute bacterial skin and skin-structure infections (ABSSSI) caused by methicillin-resistant Staphylococcus aureus: advances in phase I and II trials" @default.
- Q91525413 name "Innovative therapies for acute bacterial skin and skin-structure infections (ABSSSI) caused by methicillin-resistant Staphylococcus aureus: advances in phase I and II trials" @default.
- Q91525413 type Item @default.
- Q91525413 label "Innovative therapies for acute bacterial skin and skin-structure infections (ABSSSI) caused by methicillin-resistant Staphylococcus aureus: advances in phase I and II trials" @default.
- Q91525413 label "Innovative therapies for acute bacterial skin and skin-structure infections (ABSSSI) caused by methicillin-resistant Staphylococcus aureus: advances in phase I and II trials" @default.
- Q91525413 prefLabel "Innovative therapies for acute bacterial skin and skin-structure infections (ABSSSI) caused by methicillin-resistant Staphylococcus aureus: advances in phase I and II trials" @default.
- Q91525413 prefLabel "Innovative therapies for acute bacterial skin and skin-structure infections (ABSSSI) caused by methicillin-resistant Staphylococcus aureus: advances in phase I and II trials" @default.
- Q91525413 P1433 Q91525413-DFE3FDFD-86F6-453C-A3CF-07970BF222E5 @default.
- Q91525413 P1476 Q91525413-9BAF7301-0EAE-4D50-9546-8D3AE0511956 @default.
- Q91525413 P31 Q91525413-5C44E918-7F3D-434B-8B89-43DB33B324AC @default.
- Q91525413 P356 Q91525413-12465F9F-339A-45BC-90B1-38D09AC8D7D0 @default.
- Q91525413 P50 Q91525413-A3743A0E-90D9-4CDE-80A1-EC13437C9881 @default.
- Q91525413 P50 Q91525413-CB74375B-8A03-47A3-9262-B550D2F7F917 @default.
- Q91525413 P50 Q91525413-CC95B8EE-49BB-4CB0-BCD2-BEF4EF6729D3 @default.
- Q91525413 P50 Q91525413-CEF4382C-9AF5-456A-8179-A4BD42CF7B6B @default.
- Q91525413 P577 Q91525413-AAAB3F40-A60B-4C81-99B2-AF4D63770A87 @default.
- Q91525413 P698 Q91525413-55CA3517-ACFF-4E2D-8A00-B83A0BCE7D51 @default.
- Q91525413 P921 Q91525413-2EB74B31-00E6-4777-8F05-709D53D02E2D @default.
- Q91525413 P921 Q91525413-BFC6D945-1F39-49CF-A6F4-A5E5214D9AD7 @default.
- Q91525413 P356 13543784.2020.1750595 @default.
- Q91525413 P698 32242469 @default.
- Q91525413 P1433 Q5421208 @default.
- Q91525413 P1476 "Innovative therapies for acute bacterial skin and skin-structure infections (ABSSSI) caused by methicillin-resistant Staphylococcus aureus: advances in phase I and II trials" @default.
- Q91525413 P31 Q13442814 @default.
- Q91525413 P356 "10.1080/13543784.2020.1750595" @default.
- Q91525413 P50 Q114414999 @default.
- Q91525413 P50 Q54227864 @default.
- Q91525413 P50 Q88607142 @default.
- Q91525413 P50 Q99635167 @default.
- Q91525413 P577 "2020-04-03T00:00:00Z" @default.
- Q91525413 P698 "32242469" @default.
- Q91525413 P921 Q188121 @default.
- Q91525413 P921 Q5452194 @default.